Type IA variation for application MHRA-2022-0008. Type IA variation: New Dosage Strength for Alzabistat — major revision

Variation Number
MHRA-2022-0008-V008
Type
Type IA
Application
Status
In Progress
Fee
€1,676
Submitted
2023-06-10
Approved
—
Description

Type IA variation: New Dosage Strength for Alzabistat — major revision